Skip to main navigation Skip to search Skip to main content

rCBF-SPECT in brain infarction: when does it predict outcome?

  • M. Limburg
  • , E. A. van Royen
  • , A. Hijdra
  • , B. Verbeeten

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We prospectively studied 26 patients with ischemic stroke within 24 hr, after 2 wk, and after 6 mo with thallium-201-diethyldithiocarbamate single-photon emission computed tomography (SPECT) and neurologic and functional assessments. The admission flow deficits correlated with outcome. The admission and 6-mo scores correlated with clinical conditions at each time. At 2 wk, the flow deficits were smaller and did not correlate with clinical parameters. Nor did the presence or absence of hyperfixation of the radiopharmaceutical. Six months after the infarct, the flow defect had decreased in 9 of 15 patients in whom three serial scans were available, with better clinical improvement than in the remaining six whose flow deficits increased. More patients in the first group had been treated randomly with the calcium-entry blocker flunarizine. SPECT imaging of rCBF within 24 hr after stroke correlates with clinical outcome and condition, whereas rCBF imaging at 2 wk after the stroke shows no clinical correlation
Original languageEnglish
Pages (from-to)382-387
JournalJournal of nuclear medicine
Volume32
Issue number3
Publication statusPublished - 1991

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'rCBF-SPECT in brain infarction: when does it predict outcome?'. Together they form a unique fingerprint.

Cite this